The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Phosphates
potassium phosphate, monobasic potassium phosphate, dibasic injection, · POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL · Solution, Concentrate · Intravenous · Amneal Pharmaceuticals Private Limited
NDC 80830-1691-02 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$450.00
Reported to Texas DSHS · 2026 annual filing · Amneal Pharmaceuticals LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$325,044
555 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · label · manufacture · pack · sterilize
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- ANDA216344
- TE code
- AP
- Approval date
- Oct 10, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of potassium phosphate, monobasic potassium phosphate, dibasic injection, (Solution, Concentrate)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals Private Limited | POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL | Aug 26, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals Private Limited | POTASSIUM PHOSPHATE, MONOBASIC 236 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 224 mg/mL | Jul 22, 2026 | Aug 22, 2026 |
| Amneal Pharmaceuticals Private Limited | POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL; POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL | Jul 15, 2026 | Jul 19, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium Phosphates — NDC 80830-1691-02," retrieved September 3, 2026, https://drugdashboards.com/drug/80830169102.
Free to cite with attribution — see how the data is put together.